NXEN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 10:24):

Stats
Today's Volume	5 914.00
Average Volume	11 067.00
Market Cap	1.41M
EPS	$0 ( 2024-02-20 )
Next earnings date	( $0 ) 2024-05-17
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.09
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-31	Greenberg Richard S	Buy	250 000	Common Stock
2023-10-31	Wasoff Evan L	Buy	250 000	Common stock
2023-07-25	Goldfarb Robert I	Buy	250 000	Common Stock
2023-04-01	Goldfarb Robert I	Buy	250 000	Common Stock
2020-08-19	Goldfarb Robert I	Buy	1 000 000	Options to purchase common stock (right to buy)

INSIDER POWER
100.00
Last 97 transactions
Buy: 75 102 826 \| Sell: 17 443 467

Nexien BioPharma, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nexien BioPharma, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.00580

Q2	2024
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.000400

Q1	2024
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.00120

Q4	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.00150

Financial Reports:

No articles found.

Nexien BioPharma, Inc.

Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways for the treatment of various diseases, medical conditions, and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.